The pathology of breast cancer is complex and varied, and different symmetry corresponds to different treatment strategies. The following is a detailed description of the pathology and treatment strategy for breast cancer:
I. Pathology
Non-immersed cancer
Intra-clinic cancer: Includes powdering, physical, sifting, micro-empowerment.
In situ cancer of small leaves: Tumour cells are confined to small leaves at the end, without spreading.
Early leaching cancer
Early leaching of catheter cancer: Cancer cells begin to immerse in the surrounding tissues through the substrate.
Early leaching of leaf cancer: Cancer cells have also begun to break through the base membranes, but less so.
Leaching cancer
Vaccination of non-specific types of cancer: including leachate catheter cancer (about 65% – 80%, the most common type of breast cancer), leachate leaf cancer.
Special immersion cancers: these include marrow cancer accompanied by a large number of lymphocyte immersion, tubular cancer, mucous cancer, gland cystal cancer, breast cancer, Great Khan gland cancer, cystal cancer, paget disease, etc. These types of cancer are generally highly differentiated and relatively good.
Other rare types
These include circulatory cancer, fatty cancer, imprint cell cancer, transparent cell cancer with sugar platinum, breast cancer with silver cells, and co-chemical cancer.
Special forms of breast cancer
Inflammatory breast cancer: clinically rare, but with a high degree of malignity, the permafrost becomes more rigid, and skin red, swelling, heat, pain and oedema are visible. Sub-breast cancer: Breast cancer occurring in the outside of the normal breast, mostly in the armpits, or in the chest, groin, and outside the thigh.
Male breast cancer: Although rare, men may also have breast cancer.
II. Treatment strategy
Surgery
It’s one of the main treatments for breast cancer. Depending on the condition, breast retention can be selected (absorption of tumours and the surrounding normal tissue, breast retention) or mammography (cutting of the entire breast tissue).
For early breast cancer patients, surgical treatment often serves the purpose of rooting out.
Radiotherapy
The use of high-energy rays for tumour exposure undermines the growth and fragmentation of cancer cells.
It is often used as an auxiliary after-operative treatment to kill potential residual cancer cells and reduce relapse rates.
Chemical treatment
Cancer is controlled or eliminated by the use of anti-cancer drugs through blood circulation.
It can be used as pre-operative (newly assisted treatment) or post-operative support. Chemical treatment is particularly important in the case of tumours, lymphoma dysentery or transfer.
Endocrine treatment
It applies to hormonal positive breast cancer patients. The growth and spread of cancer cells is inhibited by influencing hormonal levels in the body or by blocking hormonal receptors. Common endocrine treatment drugs include selective estrogen receptors (e.g., mosaic), aromatic enzyme inhibitors (e.g., fluron, rening, Icemetán).
Target treatment
Treatment for intervention with specific molecular targets on breast cancer cells.
The most common target-oriented treatment is for Sher2-positive breast cancer, where the growth and spread of cancer cells is inhibited by the use of the Her2 inhibitor (e.g., one-sided anti-Hertorus).
Treatment of special types of breast cancer
Third-negative breast cancer
A specific type of breast cancer that is negative for estrogen receptor (ER), pregnancy hormone receptor (PR) and human skin growth factor (HER2). Due to the lack of endocrine and anti-HER2 targets, there is currently no targeted standard treatment programme. chemotherapy remains the main treatment option. At the same time, there are scientific teams working on potential genetic inhibitors to provide target-to-treatment drugs. Her-2 positive breast cancer
This refers to the high genetic increase of the HeR-2 in breast cancer tissues.
Patients can use drugs such as trato-chorus anti-injection fluids under the direction of a doctor, and chemical treatments such as luxol injections and dossi-tasic injections, as prescribed by the doctor.
Based on the above, the pathology of breast cancer is complex and varied, and different stratifications correspond to different treatment strategies. Doctors develop individualized treatments based on the patient ‘ s pathology type, stage of illness and physical condition. Patients should work closely with the medical team, follow the doctor ‘ s advice and actively cooperate with the treatment programme with a view to obtaining the best possible treatment results.
